Viewing StudyNCT00022906



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00022906
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-08-15

Brief Title: Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25 Bone Marrow Involvement
Sponsor: Corixa Corporation
Organization: Corixa Corporation

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkins Lymphoma
Keywords:
Name View
Iodine I 131 Tositumomab View
Non-Hodgkins Lymphoma View
Radioimmunotherapy View
Monoclonal Antibody View
Corixa View
Bexxar View
Anti-B1 Antibody View
Tositumomab View
Iodine -131 Anti-B1 Antibody View